NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.

Mangia, Anita; Scarpi, Emanuela; Partipilo, Giulia; Schirosi, Laura; Opinto, Giuseppina; Giotta, Francesco; Simone, Giovanni

Mangia, Anita; Scarpi, Emanuela; Partipilo, Giulia; Schirosi, Laura; Opinto, Giuseppina; Giotta, Francesco; Simone, Giovanni.

Afiliación

Mangia A; Functional Biomorphology Laboratory, IRCCS-Istituto Tumori "Giovanni Paolo II", Bari 70124, Italy.
Scarpi E; Unit of Biostatistics and Clinical Trials, (IRST)-IRCCS-Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FC) 47014, Italy.
Partipilo G; Functional Biomorphology Laboratory, IRCCS-Istituto Tumori "Giovanni Paolo II", Bari 70124, Italy.
Schirosi L; Functional Biomorphology Laboratory, IRCCS-Istituto Tumori "Giovanni Paolo II", Bari 70124, Italy.
Opinto G; Functional Biomorphology Laboratory, IRCCS-Istituto Tumori "Giovanni Paolo II", Bari 70124, Italy.
Giotta F; Medical Oncology Unit, IRCCS-Istituto Tumori "Giovanni Paolo II", Bari 70124, Italy.
Simone G; Pathology Department, IRCCS-Istituto Tumori "Giovanni Paolo II", Bari 70124, Italy.

Oncotarget ; 8(39): 65730-65742, 2017 Sep 12.

Article en En | MEDLINE | ID: mdl-29029467

Palabras clave

BRCA1; Na+/H+ exchanger regulatory factor 1 (NHERF1); PARP1; breast cancer; immunohistochemistry

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google